CVS HEALTH (AND SUBSIDIARIES)

Lobbying for CVS HEALTH (AND SUBSIDIARIES) · Health Care

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $3,320,000.00 expenses · posted Apr 20, 2026

Official filing document

Bills named in this filing 25

HR 2853
Combating Organized Retail Crime Act of 2025
S 1404
Combating Organized Retail Crime Act
S 2068
End Prescription Drug Ads Now Act
HR 3789
DTC Act of 2025
HR 3164
Ensuring Community Access to Pharmacist Services Act
S 2426
Equitable Community Access to Pharmacist Services Act
HR 5031
Preserving Patient Access to Long-Term Care Pharmacies Act
HR 3010
No Handouts for Drug Advertisements Act
S 1785
No Handouts for Drug Advertisements Act
S 882
Patients Before Middlemen Act
S 927
Protecting Pharmacies in Medicaid Act
S 1105
No UPCODE Act
S 3345
PBM Price Transparency and Accountability Act
HR 4317
PBM Reform Act of 2025
HR 4093
Apples to Apples Comparison Act of 2025
HR 6575
CommonGround for Affordable Health Care Act
HR 6703
Lower Health Care Premiums for All Americans Act
HR 6609
Pharmacists Fight Back in Medicare and Medicaid Act
HR 2214
DRUG Act
HR 5433
POP Act
S 2836
POP Act
HR 4409
Fair Pharmacies for Federal Employees Act of 2025
HR 6610
Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]
S 3822
Break Up Big Medicine Act
S 2099
Restore Prescription Drugs Discount Act

Lobbying activity 7

Consumer Issues/Safety/Products

Issues related to organized retail crime. H.R. 2853/S. 1404, The Combatting Organized Retail Crime Act

Advertising

S. 2068 - The End Prescription Drug Ads Now Act H.R. 3789 - The Drug-price Transparency for Consumers Act of 2025

Pharmacy

Issues related to retail pharmacy, drug pricing, and women's health. H.R. 3164 - The Ensuring Community Access to Pharmacist Services Act of 2025 S. 2426 - The Equitable Community Access to Pharmacist Services Act H.R. 5031, The Preserving Patient Access to Long-Term Care Pharmacies Act

Taxation/Internal Revenue Code

Issues related to corporate tax. H.R. 3010/S. 1785 - No Handouts for Drug Advertisement Act

Medicare/Medicaid

Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to pharmacy testing, vaccination, and treatment. Issues related to Accountable Care Organizations. Issues related to Medicare Shared Savings Program. Issues related to Medicaid. S. 882, The Patients Before Middlemen (PBM) Act S. 927, The Protecting Pharmacies in Medicaid Act S. 1105 - No Unreasonable Payments, Coding, Or Diagnoses for the Elderly Act S. 3345, The PBM Price Transparency and Accountability Act H.R. 4317, The Pharmacy Benefit Manager (PBM) Reform Act H.R. 4093, Apple to Apples Comparison Act H.R. 6575, CommonGround for Affordable Health Care Act H.R. 6703, The Lower Healthcare Premiums for All Americans Act H.R.6609, Pharmacists Fight Back in Medicare and Medicaid Act

Insurance

Issues related to employer, small group and individual insurance markets. H.R. 2214, the Delinking Revenue from Unfair Gouging (DRUG) Act H.R. 5433 - The Patients Over Profits Act S. 2836 - The Patients Over Profits Act H.R. 4409 - The Fair Pharmacies for Federal Employees Act of 2025 H.R. 6703, Lower Healthcare Premiums for All Americans Act H.R. 6610, The Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] S. 3822, Break Up Big Medicine Act

Labor Issues/Antitrust/Workplace

Issues related to the competitive nature of the pharmacy benefit manager industry and workforce issues. S. 2099, The Restore Prescription Drugs Discount Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.